These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1457500)

  • 1. Prognostic factors in non-Hodgkin's lymphoma.
    Shipp M
    Curr Opin Oncol; 1992 Oct; 4(5):856-62. PubMed ID: 1457500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic factors and predictive model of non-Hodgkin's lymphoma: pathological prognostic groupings and international prognostic index].
    Shimoyama M
    Nihon Rinsho; 2000 Mar; 58(3):602-11. PubMed ID: 10741132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of beta-integrin adhesion molecules in non-Hodgkin's lymphoma: correlation with clinical and evolutive features.
    Terol MJ; López-Guillermo A; Bosch F; Villamor N; Cid MC; Campo E; Montserrat E
    J Clin Oncol; 1999 Jun; 17(6):1869-75. PubMed ID: 10561227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of prognostic factors in non-Hodgkin's lymphoma.
    Moore DF; Cabanillas F
    Oncology (Williston Park); 1998 Oct; 12(10 Suppl 8):17-24. PubMed ID: 9830629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in Hodgkin's and non-Hodgkin's lymphomas.
    Coiffier B
    Curr Opin Oncol; 1991 Oct; 3(5):843-51. PubMed ID: 1751578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and prognostic analysis of 101 cases of primary gastrointestinal non-Hodgkin's lymphoma].
    Song LN; Cen XN; Ou JP; Liang ZY; Qiu ZX; Wang WS; Xu WL; Li Y; Wang MJ; Dong YJ; Yin Y; Sun YH; Liu W; Wang Q; Wang LH; Wang Y; Ren HY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):387-91. PubMed ID: 23628038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of treatment on the prognostic value of S-phase fraction in non-Hodgkin's lymphoma.
    Joensuu H; Ristamäki R; Söderström KO; Jalkanen S
    J Clin Oncol; 1994 Oct; 12(10):2167-75. PubMed ID: 7931487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor markers in malignant lymphoma].
    Kato H; Ogura M
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):883-92. PubMed ID: 15984537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
    Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
    J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognosis factors analysis of 56 cases of non-Hodgkin's lymphoma originating from the nasopharynx].
    Li SD; Ba YP; Zhang PW
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):651-653. PubMed ID: 31327206
    [No Abstract]   [Full Text] [Related]  

  • 11. A predictive model for aggressive non-Hodgkin's lymphoma.
    International Non-Hodgkin's Lymphoma Prognostic Factors Project
    N Engl J Med; 1993 Sep; 329(14):987-94. PubMed ID: 8141877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the adhesion molecule ICAM-1 in non-Hodgkin's lymphoma: relationship with tumor dissemination and prognostic importance.
    Terol MJ; López-Guillermo A; Bosch F; Villamor N; Cid MC; Rozman C; Campo E; Montserrat E
    J Clin Oncol; 1998 Jan; 16(1):35-40. PubMed ID: 9440720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of immunophenotype in aggressive non-Hodgkin's lymphoma.
    Tsartsidze E; Betaneli M
    Georgian Med News; 2006 May; (134):107-9. PubMed ID: 16783081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous elevation of the serum concentrations of vascular endothelial growth factor and interleukin-6 as independent predictors of prognosis in aggressive non-Hodgkin's lymphoma.
    Niitsu N; Okamato M; Nakamine H; Yoshino T; Tamaru J; Nakamura S; Higashihara M; Hirano M
    Eur J Haematol; 2002 Feb; 68(2):91-100. PubMed ID: 12038454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hodgkin's and non-Hodgkin's lymphomas.
    Rademaker J
    Radiol Clin North Am; 2007 Jan; 45(1):69-83. PubMed ID: 17157624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Hodgkin's lymphomas: immunologic prognostic studies.
    Hadzi-Pecova L; Petrusevska G; Stojanovic A
    Prilozi; 2007 Jul; 28(1):39-55. PubMed ID: 17921917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma.
    Kamath SS; Marcus RB; Lynch JW; Mendenhall NP
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):563-8. PubMed ID: 10348285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in aggressive non-Hodgkin's lymphoma: who has "high-risk" disease?
    Shipp MA
    Blood; 1994 Mar; 83(5):1165-73. PubMed ID: 8118021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for patients with diffuse large cell or immunoblastic non-Hodgkin's lymphomas: experience of the non-Hodgkin's Lymphoma Pathologic Classification Project.
    Simon R; Durrleman S; Hoppe RT; Bonadonna G; Bloomfield CD; Rudders RA; Cheson BD; Berard CW
    Med Pediatr Oncol; 1990; 18(2):89-96. PubMed ID: 2406556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Feline Hodgkin's-like lymphoma: 20 cases (1992-1999).
    Walton RM; Hendrick MJ
    Vet Pathol; 2001 Sep; 38(5):504-11. PubMed ID: 11572557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.